RE: Where's the upside from here?14 May 2020 15:36
Ghia, don't forget that NCYT market cap pre-covid in 2019 was about £23m (max 35p/share in 2019). The Market cap today is £239m, so that's £216m more or less attributable to Covid tests already. The revenue up till August could be £405m (Quickdraw's number), with profit being 50% of that, so around £202.5m. Based on that the Market may considering that today's share price is a fair price when looking at a 3-4 month look ahead of potential revenue and profit, as beyond that there is potential risk when looking further ahead than that and it is up to each individual to evaluate that risk when looking further ahead.